Aurealis Therapeutics Raises $10 Million Series A To Drive Multi-Factor Bacterial Vectors in Chronic Wounds and Oncology
Kuopio, Finland – March 30th 2023. Aurealis Therapeutics, a synthetic biology company
Source: einnews.com
Juha Yrj News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Juha Yrj. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Juha Yrj Today - Breaking & Trending Today
Collaboration brings DFU and Inflammatory Disease Therapy to Greater China Region
Aurealis Therapeutics, (Basel, Switzerland) and AI-based microbiome drug development company Xbiome have entered into an agreement for the clinical development and commercialisation of Aurealis’ investigational Diabetic Foot Ulcer (DFU) and other chronic wounds and inflammatory disease therapy in the Greater China territory. Click to read more...
Source: labmate-online.com
Aurealis Therapeutics and Xbiome Enter into a License and Collaboration Agreement for Aurealis Four-in-One Diabetic Foot Ulcer and Inflammatory Disease Cell and Gene Therapy AUP-16 in Greater China
/PRNewswire/ -- Aurealis Therapeutics, a synthetic biology company developing groundbreaking four-in-one cell and gene therapies and Xbiome, an AI-based...
Source: prnewswire.com
Aurealis Therapeutics AG: Aurealis Therapeutics and Xbiome Enter into a License and Collaboration Agreement for Aurealis Four-in-One Diabetic Foot Ulcer and Inflammatory Disease Cell and Gene Therapy AUP-16 in Greater China
BASEL, Switzerland, KUOPIO, Finland, and SHENZHEN, China, Jan. 28, 2022 /PRNewswire/ -- Aurealis Therapeutics, a synthetic biology company developing groundbreaking four-in-one cell and gene
Source: finanznachrichten.de